NEW YORK, August 15, 2026, 06:54 EDT — U.S. markets remain closed for the weekend.
- UiPath gained 6.4% over the past week and is up 25.5% since July 31.
- PATH shares are trading 20.8% higher than the most recent analyst consensus price target of $13.25.
- Guidance for the second quarter continues to indicate a sequential revenue decline of 4.9%.
UiPath Inc. NYSE:PATH ended Friday trading at $16.01. Shares rose 6.4% over the week, though they dropped 4.0% on the final day. The stock stands 25.5% higher since the close on July 31.
The surge has shifted the focus for investors. PATH trades 20.8% higher than the current $13.25 analyst consensus target. Its price has also surpassed the most recent targets issued by UBS, BMO Capital, DA Davidson and Bank of America.
The gains were widespread. UiPath outpaced the two main indexes as well as the iShares Expanded Tech-Software Sector ETF (NYSEARCA:IGV) during the past week. The data below shows the change in Friday-to-Friday closing prices.
| Security | Aug. 7 close | Aug. 14 close | Weekly change |
|---|---|---|---|
| UiPath NYSE:PATH | $15.05 | $16.01 | up 6.4% |
| iShares software ETF (NYSEARCA:IGV) | $102.69 | $104.08 | rose 1.4% |
| S&P 500 | 7,757.64 | 7,785.76 | added 0.4% |
| Nasdaq Composite | 26,690.62 | 26,729.16 | increased 0.1% |
Most of the gains came on Thursday. PATH climbed 9.3% to $16.68, before giving up some of those gains on Friday. Trading volume on Friday was about 52.1 million shares, which was lower than the three-month daily average of 64.4 million.
| Market measure | Friday value | Comparison |
|---|---|---|
| Closing price | $16.01 | 25.5% higher than July 31 |
| 50-day average | $11.90 | PATH is 34.5% above average |
| 200-day average | $12.74 | PATH stands 25.7% over average |
| 52-week range | $9.20–$19.84 | 19.3% under the peak |
| Forward P/E | 17.7 times | Reflects current forecasts |
| Market value | $8.30 billion | Value at Friday’s close |
The core argument is supported by improved first-quarter results. Revenue climbed 17% to $418 million. Annual recurring revenue was up 12% to $1.901 billion, and GAAP operating income totaled $28 million.
Daniel Dines, founder and CEO, stated that UiPath’s “agentic products are moving from pilot to production.” The company posted net new ARR of $49 million, rising from $27 million in the prior year. UiPath first-quarter filing
The immediate challenge is more difficult. UiPath projected second-quarter revenue in the range of $395 million to $400 million. The midpoint of $397.5 million represents a 4.9% decrease compared to the prior quarter, yet marks a 9.8% increase year over year.
| Metric | Q1 FY2027 actual | Q2 FY2027 midpoint | Sequential change | Q2 FY2026 actual |
|---|---|---|---|---|
| Revenue | $418 million | $397.5 million | -4.9% | $362 million |
| ARR | $1.901 billion | $1.932 billion | +1.6% | $1.723 billion |
| Non-GAAP operating income | $92 million | $75 million | -18.5% | $62 million |
Wall Street sentiment has yet to align with market movements. The prevailing consensus stays at Neutral. Most recent price targets fall between $12 and $13, suggesting a potential decline of 19% to 25% from the close on Friday.
| Analyst or consensus | Latest rating | Target | Implied move from $16.01 | Date |
|---|---|---|---|---|
| UBS | Hold | $12 | -25.0% | June 29 |
| BMO Capital | Hold | $13 | -18.8% | June 1 |
| DA Davidson | Hold | $12 | -25.0% | May 29 |
| Bank of America | Sell | $13 | -18.8% | May 29 |
| 16-analyst consensus | Neutral | $13.25 | -17.2% | Latest available |
The most recent SEC filing did not contain an operational update. Chief Accounting Officer Hitesh Ramani disposed of 50,000 shares over Thursday and Friday, totaling roughly $831,250. The transactions were executed under a Rule 10b5-1 trading plan adopted March 25, limiting their interpretation as a new discretionary move. Ramani continues to hold 235,052 shares directly.
In the coming week, investors will assess if Thursday’s breakout remains intact. The $16 mark is key, standing notably higher than current analyst targets. UiPath’s next earnings report is set for September 3 after market close.
Risks: The rally may lose momentum if ARR growth decelerates or analysts maintain current targets. Competitive pressure from Microsoft Corp. NASDAQ:MSFT, ServiceNow Inc. NYSE:NOW and other automation providers is still strong. Softer spending conditions could further postpone major enterprise agreements.
The data suggest limited options. UiPath needs to turn agentic-AI adoption into accelerated recurring revenue and stable margins. Failing that, maintaining the stock’s recent premium will be a challenge.
Related articles: NYSE:PATH
